PA
Perceptive Advisors’s Spyre Therapeutics SYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.9M | Sell |
1,529,445
-783,827
| -34% | -$11.7M | 0.85% | 30 |
|
|
2025
Q1 | $37.3M | Sell |
2,313,272
-261,451
| -10% | -$4.22M | 1.32% | 22 |
|
|
2024
Q4 | $59.9M | Sell |
2,574,723
-297,824
| -10% | -$6.93M | 1.65% | 17 |
|
|
2024
Q3 | $84.5M | Sell |
2,872,547
-158,471
| -5% | -$4.66M | 1.79% | 15 |
|
|
2024
Q2 | $71.3M | Buy |
3,031,018
+474,339
| +19% | +$11.2M | 1.72% | 15 |
|
|
2024
Q1 | $97M | Sell |
2,556,679
-50,000
| -2% | -$1.9M | 1.7% | 16 |
|
|
2023
Q4 | $56.1M | Buy |
2,606,679
+2,525,563
| +3,114% | +$54.4M | 1.25% | 23 |
|
|
2023
Q3 | $994K | Buy |
+81,116
| New | +$994K | 0.03% | 79 |
|
|
2018
Q3 | – | Sell |
-25,694
| Closed | -$272K | – | 127 |
|
|
2018
Q2 | $272K | Buy |
+25,694
| New | +$272K | 0.01% | 119 |
|
|
2017
Q2 | – | Sell |
-5,833
| Closed | -$43K | – | 149 |
|
|
2017
Q1 | $43K | Sell |
5,833
-97,752
| -94% | -$721K | ﹤0.01% | 135 |
|
|
2016
Q4 | $451K | Hold |
103,585
| – | – | 0.03% | 122 |
|
|
2016
Q3 | $664K | Sell |
103,585
-2,308
| -2% | -$14.8K | 0.04% | 102 |
|
|
2016
Q2 | $515K | Buy |
+105,893
| New | +$515K | 0.04% | 107 |
|